aqueous acid catalyzed nucleophilic acyl substitution from the ketone to the hydroxy alcohol
Under acidic conditions, the carbonyl group (the ketone) of an acyl compound can become protonated, which activates it towards nucleophilic attack. Next, the protonated carbonyl can be attacked by a nucleophile to give a tetrahedral intermediate, which center would be the beta carbon, and the legs would be the benzene ring carbon (R1) the alpha carbon (R2) the hydroxyl and the added hydrogen at the beta carbon now that the beta carbon only has a single bond to the oxygen -- and it would be stable until methylated making the hydroxy into a methoxy (which happens to hydroxyls in the liver quite often)
If only 10% of the dose was acted upon by this it puts BOHB at 15-30 mg from a 150-300 mg dose of bk-2C-b most of the BOHB should convert to BOB = 12-24 mg BOB
lmao where are you getting this information from...
O-methylation happens a bit in the brain (e.g. catechol-O-methyltransferase) and it's not for metabolic purposes but rather to modulate neurotransmitter action.
Why would the liver methylate a hydroxyl and make the metabolite more lipophilic, and thus harder to excrete?
Hydroxyls are usually conjugated with glucuronic acid (this is called phase 2 metabolism).
Where is your "added hydrogen" going to come from lol? It ain't gonna magically appear from nowhere. If you want to nucleophilically add a hydrogen to a ketone or other reducible group, you need what is called a "hydride donor" or a reducing agent. Lab examples are LiAlH4 and NaCNBH3. The drug has to undergo a change in oxidation state. Our body uses NADH, which doesn't float around in stomach acid. You'll also require an enzyme to carry out the reduction, and these metabolic enzymes are only expressed in hepatocytes. They too will not be found in stomach acid.
I'd also like to point out that 2-CB absolutely cannot be methylated to DOB in vivo. That is incorrect (sorry lol). Methylation in the body normally uses S-adenosyl methionine as an electrophilic methyl donor, along with an enzyme to accomodate for the particular reaction substrates. Even if 2-CB were converted to 2-(2,5-dimethoxy-4-bromophenyl)-ethanal by pyridoxal phosphate and some aminotransferase enzyme, it would then need a nucleophilic methyl donor, an oxidation to the ketone again and finally another reaction with pyridoxamine phosphate. This simply will not happen, for too many reasons.
Another point: "hydrolysis" specifically means when a bond is cleaved with water. So the reaction of bk-2-CB --> BOHB cannot be called a hydrolysis. As mentioned, this reaction is a reduction, because the beta carbon drops in oxidation state.
A very general rule to predict metabolic reactions is to compare polarities of the metabolites. A metabolic conversion that lowers the logP of a metabolite is likely to happen as it makes the drug easier to excrete. Adding methyl groups to random places on a molecule doesn't really accomplish this, so it generally is not observed in metabolic reactions. A few examples: aromatic rings are hydroxylated via epoxide intermediates (watch out, these intermediates can alkylate various things such as DNA and this is why benzene and other aromatic compounds can be carcinogenic). Esters are hydrolysed to leave polar carboxylic acids. Ethers are demethylated and prepared for conjugation. Aldehydes are oxidised to carboxylic acids. Benzylic/reactive carbons are oxidised as well (e.g toluene --> benzoic acid).
If you want to learn more about this stuff I recommend reading this book:
https://www.amazon.co.uk/Organic-Chemistry-Jonathan-Clayden/dp/0198503466
And then this book:
https://www.amazon.co.uk/Introduction-Medicinal-Chemistry-Graham-Patrick/dp/0199234477
The most likely reason to your question about bk-2-CB lasting long is that greater dosages take longer to excrete. You've probably heard of people tripping for much longer than they bargained for by taking an extremely large dose of LSD or Bromo-Dragonfly.